noscript

News and Announcements

Proteomics Investigates Biomarkers for Mesothelioma

  • Published September 08, 2016 4:53PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

6th September 2016, ASX Announcement

  • PILL commences the search for protein biomarkers in the blood that could be used to diagnose mesothelioma.
  • World Health Organisation estimates put the cost of treatment, compensation and settlement upwards of AU$667,00 for every sufferer.
  •  Mesothelioma kills 59,000 people annually.

Perth life sciences company Proteomics International Laboratories Limited (PILL, ASX: PIQ) has begun the detailed search for proteins associated with asbestos mesothelioma.

The research aim to develop a simple blood test for the disease, which could lead to early diagnosis for some of the many thousands of currently undiagnosed people who will die from mesothelioma each year.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now